Boston Scientific logo

BSX - Boston Scientific Share Price

$43.82 0.6  1.4%

Last Trade - 3:06pm

Sector
Healthcare
Size
Large Cap
Market Cap £46.05bn
Enterprise Value £54.16bn
Revenue £7.95bn
Position in Universe 177th / 6416
Bullish
Bearish
Unlock BSX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BSX Revenue Unlock BSX Revenue

Net Income

BSX Net Income Unlock BSX Revenue

Normalised EPS

BSX Normalised EPS Unlock BSX Revenue

PE Ratio Range

BSX PE Ratio Range Unlock BSX Revenue

Dividend Yield Range

BSX Dividend Yield Range Unlock BSX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BSX EPS Forecasts Unlock BSX Revenue
Profile Summary

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated June 22, 1979
Public Since May 19, 1992
No. of Shareholders: 8,087
No. of Employees: 32,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 1,393,823,592
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BSX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BSX
Upcoming Events for BSX
Similar to BSX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.